UBS analyst AJ Rice reiterated a Buy rating and $31.00 price target on BrightSpring Health (NASDAQ: BTSG).The analyst commented, "Management ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE